These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
747 related articles for article (PubMed ID: 28409203)
1. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections. Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA; Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203 [TBL] [Abstract][Full Text] [Related]
2. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity. Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive Guidance for Antibiotic Dosing in Obese Adults. Meng L; Mui E; Holubar MK; Deresinski SC Pharmacotherapy; 2017 Nov; 37(11):1415-1431. PubMed ID: 28869666 [TBL] [Abstract][Full Text] [Related]
4. Optimisation of antimicrobial dosing based on pharmacokinetic and pharmacodynamic principles. Hoo GSR; Liew YX; Kwa AL Indian J Med Microbiol; 2017; 35(3):340-346. PubMed ID: 29063877 [TBL] [Abstract][Full Text] [Related]
5. Ensuring target concentrations of antibiotics in critically ill patients through dose adjustment. Gorham J; Taccone FS; Hites M Expert Opin Drug Metab Toxicol; 2022 Mar; 18(3):177-187. PubMed ID: 35311440 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care Unit. Williams P; Cotta MO; Roberts JA Semin Respir Crit Care Med; 2019 Aug; 40(4):476-487. PubMed ID: 31585474 [TBL] [Abstract][Full Text] [Related]
7. From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics. Wicha SG; Märtson AG; Nielsen EI; Koch BCP; Friberg LE; Alffenaar JW; Minichmayr IK; Clin Pharmacol Ther; 2021 Apr; 109(4):928-941. PubMed ID: 33565627 [TBL] [Abstract][Full Text] [Related]
8. Optimizing dosing of antibiotics in critically ill patients. Parker SL; Sime FB; Roberts JA Curr Opin Infect Dis; 2015 Dec; 28(6):497-504. PubMed ID: 26382000 [TBL] [Abstract][Full Text] [Related]
9. How severe is antibiotic pharmacokinetic variability in critically ill patients and what can be done about it? Felton TW; Hope WW; Roberts JA Diagn Microbiol Infect Dis; 2014 Aug; 79(4):441-7. PubMed ID: 24985764 [TBL] [Abstract][Full Text] [Related]
10. Development of a dosing algorithm for meropenem in critically ill patients based on a population pharmacokinetic/pharmacodynamic analysis. Ehmann L; Zoller M; Minichmayr IK; Scharf C; Huisinga W; Zander J; Kloft C Int J Antimicrob Agents; 2019 Sep; 54(3):309-317. PubMed ID: 31229669 [TBL] [Abstract][Full Text] [Related]
11. How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics. Roberts JA; Joynt GM; Choi GY; Gomersall CD; Lipman J Int J Antimicrob Agents; 2012 Mar; 39(3):187-92. PubMed ID: 22226651 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic aspects of beta-lactam antibiotic therapy in intensive care unit patients: A one-center experience with TDM. Sadilová K; Halačová M; Černý D Ceska Slov Farm; 2020; 69(1):17-23. PubMed ID: 32460506 [TBL] [Abstract][Full Text] [Related]
13. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy. Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections? Muller AE; Huttner B; Huttner A Drugs; 2018 Mar; 78(4):439-451. PubMed ID: 29476349 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients. Veiga RP; Paiva JA Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of β-lactam antibiotics in the ICU. Dhaese S; Van Vooren S; Boelens J; De Waele J Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1155-1164. PubMed ID: 32597263 [TBL] [Abstract][Full Text] [Related]
17. Optimising β -lactam Dosing in Neonates: A Review of Pharmacokinetics, Drug Exposure and Pathogens. Fuchs A; Li G; van den Anker JN; Bielicki J Curr Pharm Des; 2017; 23(38):5805-5838. PubMed ID: 28950814 [TBL] [Abstract][Full Text] [Related]
18. β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia. Hayashi Y; Lipman J; Udy AA; Ng M; McWhinney B; Ungerer J; Lust K; Roberts JA Int J Antimicrob Agents; 2013 Feb; 41(2):162-6. PubMed ID: 23153962 [TBL] [Abstract][Full Text] [Related]
19. Can we transfer pharmacokinetics/pharmacodynamics of antimicrobials into clinical practice? Scaglione F Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S40-2. PubMed ID: 26607342 [TBL] [Abstract][Full Text] [Related]
20. Antibiotic therapy in sepsis: No next time for a second chance! Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]